[{"Assets_0_Q3_USD":422642000.0,"CommonStockSharesConverted_0_Q3_shares":11728232.0,"CommonStockSharesOutstanding_0_Q3_shares":11728232.0,"EarningsPerShareBasic_1_Q3_USD":-4.6,"EarningsPerShareBasic_3_Q3_USD":-11.53,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-90747000.0,"NetIncomeLossConverted_1_Q3_USD":-48314000.0,"NetIncomeLossConverted_3_Q3_USD":-110912000.0,"RevenuesConverted_1_Q3_USD":1403000.0,"RevenuesConverted_3_Q3_USD":7111000.0,"StockholdersEquity_0_Q3_USD":-280797000.0,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191119"}]